The data suggest that in TNBS colitis, Setd2-deficient Treg cells are defective in suppressing Th1 but not Th17 responses, which may be controlled by the retained inhibitory function of RORγt+ Treg cells47. The gene discussed is SETD2; the disease is colitis.